In force

Tramadol excretion study administered orally for the improvement of detection of these substances in anti-doping controls (clinical part)

Principal investigator
R. de la Torre
Country
Spain
Institution
Institut Municipal d’Investigacio Medica (IMIM)
Year approved
2022
Status
Live

Project description

Code: T22M01RTRV - Part 1

Salbutamolwas included in the prohibited list of the World Anti-Doping Agency (WADA) in 2004. While systemic salbutamol is banned, inhaled salbutamol is permitted but with dosage regimen restrictions. The dose should indeed not exceed “1600 µg over 24 hours in divided doses not to exceed 800 µg over.